SCHEMBL21149652

SCHEMBL21149652

CCC(C)OC(=O)NC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.36
ALDH1A1 P00352 2/20 0.34
GAA P10253 1/20 0.34
CTSK P43235 4/20 0.33
CTSL P07711 1/20 0.33
CTSB P07858 1/20 0.33
CTSH P09668 1/20 0.33
MAPT P10636 1/20 0.32
TUBB4A P04350 1/20 0.32
TUBB P07437 1/20 0.32
TUBA3C P0DPH7 1/20 0.32
TUBA1B P68363 1/20 0.32
TUBA4A P68366 1/20 0.32
TUBB4B P68371 1/20 0.32
TUBB3 Q13509 1/20 0.32
TUBB2A Q13885 1/20 0.32
TUBB8 Q3ZCM7 1/20 0.32
TUBA3E Q6PEY2 1/20 0.32
TUBA1A Q71U36 1/20 0.32
TUBA1C Q9BQE3 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16912703 0.83 POLB (0.36) POLBALDH1A1GAACTSKCTSL
SCHEMBL28603652 0.83 POLB (0.36) POLBALDH1A1GAACTSKCTSL
SCHEMBL16912704 0.83 POLB (0.36) POLBALDH1A1GAACTSKCTSL
SCHEMBL5861571 0.82 KDM4C (0.42) CTSKCTSLCTSBCTSHMAPT
SCHEMBL28716764 0.82 POLB (0.35) POLBALDH1A1GAACTSKCTSL
SCHEMBL28012866 0.82 POLB (0.35) POLBALDH1A1GAACTSKCTSL
SCHEMBL28966629 0.82 POLB (0.35) POLBALDH1A1GAACTSKCTSL
SCHEMBL27893659 0.82 POLB (0.35) POLBALDH1A1GAACTSKCTSL
SCHEMBL27910731 0.82 POLB (0.35) POLBALDH1A1GAACTSKCTSL
SCHEMBL28762365 0.81 POLB (0.32) POLBALDH1A1GAACTSKCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10774053-B2 HIV protease inhibitors GILEAD SCIENCES, INC. (US) 2020-09-15 US disclosed
US-20190210978-A1 HIV PROTEASE INHIBITORS GILEAD SCIENCES, INC. (US) 2019-07-11 US disclosed
CN-1075808-C Aniline derivatives having nitric oxide synthase inhibitory activity CHUGAI PHARMACEUTICAL CO LTD (JP) 2001-12-05 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10774053-B2 HIV protease inhibitors PRSS1, SERPINB1, FURIN POLB 1786/4885ALDH1A1 1247/4885GAA 80/4885
US-20190210978-A1 HIV PROTEASE INHIBITORS PRSS1, SERPINB1, HPN POLB 2064/4885ALDH1A1 1705/4885GAA 130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.